Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis

Critical Care Medicine
Andre C KalilMark E Rupp

Abstract

Compared with glycopeptides, linezolid achieves higher lung epithelial lining fluid concentrations, which may correlate with improved efficacy in the treatment of nosocomial pneumonia. However, clinical superiority has not been demonstrated. To test the hypothesis that linezolid may be superior to glycopeptides. Prospective randomized trials that tested linezolid vs. vancomycin or teicoplanin for treatment of nosocomial pneumonia were included. Heterogeneity was analyzed by I(2) and Q statistics. Meta-analysis relative risks were based on fixed and random-effects models. Outcomes evaluated consisted of clinical cure, microbiological eradication, and side effects. Nine linezolid trials (vancomycin [7]; teicoplanin [2]) were included (n = 2329). The linezolid vs. glycopeptide analysis shows clinical cure relative risk of 1.01 (95% confidence interval, 0.93-1.10; p = .83; I(2) = 0%) and microbiological eradication relative risk of 1.10 (95% confidence interval, 0.98 -1.22; p = .10; I(2) = 0%). Methicillin-resistant Staphylococcus aureus subgroup analysis yielded a microbiological eradication relative risk of 1.10 (95% confidence interval, 0.87-1.38; p = .44; I(2) = 16%). If linezolid is compared with vancomycin only, then clinical...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
May 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H GeorgesG Beaucaire
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E RubinsteinUNKNOWN Linezolid Nosocomial Pneumonia Study Group
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Jean Chastre, Jean-Yves Fagon
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·John E ConteElisabeth Zurlinden
May 17, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensBarry Hafkin
May 15, 2003·The Journal of Antimicrobial Chemotherapy·David HoneybourneRichard Wise
Jul 11, 2003·Clinical Therapeutics·Richard G WunderinkUNKNOWN Linezolid Nosocomial Pneumonia Study Group
Aug 13, 2003·The Pediatric Infectious Disease Journal·Sheldon L KaplanUNKNOWN Linezolid Pediatric Study Group
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jan 20, 2004·The Journal of Antimicrobial Chemotherapy·Mark WilcoxMatthew Dryden
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Branimir JaksicKenneth J Tack
Sep 12, 2007·Antimicrobial Agents and Chemotherapy·Sungmin Kiem, Jerome J Schentag

❮ Previous
Next ❯

Citations

Mar 23, 2011·Der Anaesthesist·S WeitererC Lichtenstern
Mar 14, 2012·European Journal of Clinical Pharmacology·Sepideh ElyasiAmirhooshang Mohammadpour
Apr 10, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H JiangJ Wang
Mar 21, 2012·Current Infectious Disease Reports·Jason C KwongPatrick G P Charles
Jan 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard G WunderinkJean Chastre
Jan 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antoni Torres
Dec 17, 2011·The Journal of Antimicrobial Chemotherapy·Nimish PatelThomas P Lodise
Dec 20, 2012·The Journal of Antimicrobial Chemotherapy·S J VandecasteeleE Tacconelli
Mar 26, 2013·Current Opinion in Pulmonary Medicine·François BarbierLila Bouadma
Apr 20, 2011·Artificial Organs·Stefan WeilerRomuald Bellmann
Jul 27, 2011·Antimicrobial Agents and Chemotherapy·Krishna MuppidiAndrew S Pumerantz
Sep 29, 2012·Lung India : Official Organ of Indian Chest Society·Dheeraj GuptaUNKNOWN Pneumonia Guidelines Working Group
Apr 8, 2014·European Journal of Pediatrics·Maria IoannidouEmmanuel Roilides
Nov 28, 2014·Intensive Care Medicine·Girish B Nair, Michael S Niederman
Feb 24, 2015·Journal of Intensive Care·Shigeto OdaUNKNOWN Sepsis Registry Committee of The Japanese Society of Intensive Care Medicine
Sep 25, 2012·International Journal of Antimicrobial Agents·Yasuhisa AbeSoichi Arakawa
Apr 6, 2013·International Journal of Clinical Practice·T-J LiX-D Li
Dec 18, 2013·Acta Paediatrica. Supplement·L GalliM de Martino
Aug 30, 2011·The American Journal of Cardiology·Shuning ZhangJuying Qian
Nov 27, 2010·The Lancet Infectious Diseases·Ian M Gould
Aug 25, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Curtis D Collins, Ann K Schwemm
Dec 27, 2011·International Journal of Antimicrobial Agents·Ian M GouldGeorg Peters
Nov 15, 2011·Expert Opinion on Pharmacotherapy·Ethan RubinsteinZeina A Kanafani
Jun 28, 2015·Current Infectious Disease Reports·Braden Waters, John Muscedere
Jun 21, 2015·Current Infectious Disease Reports·Kristina L Bailey, Andre C Kalil
Oct 24, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jesse T Jacob, Carlos A DiazGranados
Jul 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andre C KalilJan L Brozek
Mar 26, 2014·The Annals of Pharmacotherapy·David R WilliamsonDanielle Pilon
Dec 13, 2012·The Annals of Pharmacotherapy·Marisel Segarra-Newnham, Timothy J Church
Oct 25, 2017·Clinical Pharmacokinetics·Claire RogerLaurent Muller
Aug 10, 2012·British Journal of Hospital Medicine·B Edwards, Im Gould
Oct 17, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Dana R BowersAmy N Schilling
Apr 25, 2019·Critical Reviews in Analytical Chemistry·Guilherme Felipe Dos Santos FernandesJean Leandro Dos Santos
Sep 30, 2017·The Journal of Antimicrobial Chemotherapy·V Ramos-MartínW W Hope

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.